Why Amgen Inc. (AMGN) is One of the Best Stem Cell Therapy Stocks to Buy
Amgen Inc. (NASDAQ:AMGN) is one of the best stem cell therapy stocks to buy. Canaccord initiated coverage of Amgen Inc. (NASDAQ:AMGN) with a Hold rating on April 21, setting a price target of $366.








